Evidence map›Paper›PMID 1430199›Full record

ArticleThe Journal of clinical investigation1992

Glutaric acidemia type II. Heterogeneity in beta-oxidation flux, polypeptide synthesis, and complementary DNA mutations in the alpha subunit of electron transfer flavoprotein in eight patients.

E Freneaux, V C Sheffield, L Molin, A Shires, W J Rhead

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. New Regulatory roles for Human Serum Amyloid A.International journal of research in oncology · 2024
    Article
  4. Article
  5. Review
  6. Genome-Wide Association Studies in Glioma.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Three-dimensional structure of human electron transfer flavoprotein to 2.1-A resolution.Proceedings of the National Academy of Sciences of the United States of America · 1996
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

E FreneauxDepartment of Pediatrics, University of Iowa, Iowa City 52242.
V C Sheffield
L Molin
A Shires
W J Rhead
University of Iowa · USMedical Genetics Center · DE

Funding

UNIVERSITY OF IOWA CHILD HEALTH RESEARCH CENTERP30HD027748 · NICHD · UNIVERSITY OF IOWA · PI MORRISS, FRANK H · 1990 to 2001
$640k
INHERITED DISORDERS OF OXIDATIVE METABOLISM IN MANR01DK033289 · NIDDK · UNIVERSITY OF IOWA · PI RHEAD, WILLIAM J. · 1986 to 1991
–
IMPROVED MUTATION DETECTION &HIGH THROUGHPUT GENOTYPINGR01HG000457 · NHGRI · UNIVERSITY OF IOWA · PI SHEFFIELD, VAL C · 1991 to 1996
–
NHGRI NIH HHS HG00457NICHD NIH HHS P30HD27748NIDDK NIH HHS DK-33289
6 · The paper itself

Abstract

We studied metabolic, polypeptide and genetic variation in eight glutaric acidemia type II (GA II) patients with electron transfer flavoprotein (ETF) deficiency. As measured by 3H-fatty acid oxidations in fibroblasts, beta-oxidation pathway flux correlated well with clinical phenotypes. In six patients with severe neonatal onset GA II, oxidation of [9,10(n)-3H]-palmitate ranged from 2% to 22% of control and of [9,10(n)-3H]myristate, from 2% to 26% of control. Of two patients with late onset GA II, one had intermediate residual activities with these substrates and the other normal activities. Radiolabeling and immunoprecipitation studies revealed that three of the six neonatal onset GA II patients had greatly diminished or absent alpha- and beta-ETF subunits, consistent with a failure to assemble a stable heterodimer. Another neonatal onset patient showed normal synthesis of beta-ETF but decreased synthesis of alpha-ETF. Two neonatal onset and two late onset GA II patients showed normal synthesis of both subunits. Analysis of the pre-alpha-ETF coding sequence revealed seven different mutations in the six patients with neonatal onset GA II. The most common mutation was a methionine for threonine substitution at codon 266 found in four unrelated patients, while all the other mutations were seen in single patients. No mutations were detected in the two patients with late onset GA II.

Indexed as

Peptide BiosynthesisAmino Acid Metabolism, Inborn ErrorsBase SequenceCells, CulturedDNAElectron-Transferring FlavoproteinsFatty AcidsFlavoproteinsGlutaratesHumansLipid Metabolism, Inborn ErrorsMolecular Sequence DataMutationOxidation-ReductionPolymerase Chain ReactionDNAElectron-Transferring FlavoproteinsFatty AcidsFlavoproteinsGlutaratesglutaric acid

Identifiers

PMID1430199
PMCPMC443224
OpenAlexW2085444983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.